The potentiation of neuromuscular blocking agents by quinidine.
D000818:Animals; D002415:Cats; D003650:Decamethonium Compounds / Q000494:pharmacology; D003964:Diaphragm; D004357:Drug Synergism; D005703:Gallamine Triethiodide / Q000494:pharmacology; D005730:Ganglionic Blockers / Q000494:pharmacology*; D066298:In Vitro Techniques; D009132:Muscles / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects*; D010791:Phrenic Nerve; D011802:Quinidine / Q000494:pharmacology*; D051381:Rats; D012584:Sciatic Nerve; D013390:Succinylcholine / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D003650:Decamethonium Compounds; D005730:Ganglionic Blockers; D011802:Quinidine; D013390:Succinylcholine; D005703:Gallamine Triethiodide; D014403:Tubocurarine